先端分野の市場情報を提供する株式会社グローバルインフォメーション（神奈川県川崎市、代表取締役社長：小野 悟）は、2012年1月31日～2月1日 米国、サンディエゴにて開催されます、Cambridge Healthtech Institute主催 国際学会「Biomarker Assay Development （バイオ ...
先端分野の市場情報を提供する株式会社グローバルインフォメーション（神奈川県川崎市、代表取締役 社長：小野 悟）は、2011年1月31～2月2日 米国、サンディエゴにて開催されます、Cambridge Healthtech Institute主催 国際会議・展示会「Biomarker Assay Development ...
Perceptive Discovery, the preclinical and translational services division of Perceptive, today announced a $15M series of ...
We spoke with Scott Jones, PhD, SVP & CSO at BioBridge Global (BBG) to understand the challenges of product-specific potency ...
VENLO, Netherlands, June 18, 2025--(BUSINESS WIRE)--QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) and GENCURIX, Inc. (KOSDAQ: 229000) today announced a new partnership to develop oncology assays ...
REDDING, Calif., Oct. 24, 2024 /PRNewswire/ -- According to a new market research report, 'IVD Assay Development Market Size, Share, Forecast, & Trends Analysis by Offering (Assay Development, ...
The COVID-19 pandemic and geopolitical conflict in Eastern Europe have done irreparable damage to the underpinnings of the clinical diagnostic industry. These events significantly impacted the supply ...
Understanding Interactions Leads to Better Assays as well as Time and Cost Savings Thorough elucidation of biomolecular interactions is central to understanding biology and disease mechanisms and ...
News-Medical.Net on MSN
Accelerating kinase drug discovery with validated kinase activity assay kits
The development of new therapeutics targeting protein kinases is crucial in the fight against diseases like cancer. Kinase drug discovery programs rely on the precise characterization and screening of ...
FREMONT, Calif., Feb. 24, 2025 /PRNewswire/ -- Alamar Biosciences, a company powering precision proteomics to enable the earliest detection of disease, is proud to announce the release of the ...
一部の結果でアクセス不可の可能性があるため、非表示になっています。
アクセス不可の結果を表示する
フィードバック